The Impact of Short Stature on Health-Related Quality of Life in Children with Chronic Kidney Disease - 22/08/13
Chronic Kidney Disease in Children (CKiD) Study Group∗
Abstract |
Objectives |
To compare the health-related quality of life (HRQoL) of children with chronic kidney disease (CKD) and short stature (SS) with that of children with CKD and normal height (NH), to evaluate the impact of catch-up growth and growth hormone (GH) use on HRQoL, and to describe the concordance of perceptions of HRQoL between children with SS and NH and their parents.
Study design |
Four hundred eighty-three children and/or parents enrolled in the multicenter Chronic Kidney Disease in Children study who had completed the Pediatric Quality of Life Inventory (Version 4.0) on at least 2 Chronic Kidney Disease in Children study visits composed this substudy population. Participants were dichotomized into NH or SS groups. The demographic characteristics that varied at baseline (sex, glomerular filtration rate, and parent education) were controlled for in the main analysis evaluating the impact of catch-up growth and use of GH on HRQoL.
Results |
Multivariate modeling (controlling for confounding variables) revealed a significant association between both catch-up growth and GH use on parent–proxy reports of child physical functioning (P < .05) and social functioning (P < .05). Older children with CKD (15-17 years old) had significantly higher ratings than their parents on the Pediatric Quality of Life Inventory Physical, Emotional, Social, and School Functioning scales compared with younger children (8-14 years old).
Conclusion |
The finding that height gains and GH use are associated with increases in physical and social functioning by parent report provides additional support for interventions to improve height in children with CKD. The importance of evaluating both the parent and child perceptions of HRQoL is supported by our results.
Le texte complet de cet article est disponible en PDF.Keyword : CKD, CKiD, eGFR, GH, HRQoL, ieGFR, iGFR, ME, NH, PedsQL, SS
Plan
| Funded by the National Institute of Diabetes and Digestive and Kidney Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Heart, Lung, and Blood Institute (UO1-DK-66143, UO1-DK-66174, U01-DK-82194, and UO1-DK-66116). The authors are solely responsible for the data analysis, and interpretation of data, in the writing of the report, and the decision to submit the paper for publication. The authors declare no conflicts of interest. |
|
| Registered with ClinicalTrials.gov: NCT00327860. |
Vol 163 - N° 3
P. 736 - septembre 2013 Retour au numéro
Article précédent
- Predictors of Screening and Injury in Contacts of Physically Abused Children
- Daniel M. Lindberg, Emily A. Blood, Kristine A. Campbell, Antoinette L. Laskey, Rachel P. Berger, Examining Siblings to Recognize Abuse (ExSTRA) Study Group ?
- Clinical and Molecular Spectrum of Renal Malformations in Kabuki Syndrome
- Jean-Benoît Courcet, Laurence Faivre, Caroline Michot, Antoine Burguet, Stéphanie Perez-Martin, Eudeline Alix, Jeanne Amiel, Clarisse Baumann, Marie-Pierre Cordier, Valérie Cormier-Daire, Marie Ange Delrue, Brigitte Gilbert-Dussardier, Alice Goldenberg, Marie-Line Jacquemont, Aurélia Jaquette, Honorine Kayirangwa, Didier Lacombe, Martine Le Merrer, Annick Toutain, Sylvie Odent, Anne Moncla, Anna Pelet, Nicole Philip, Lucille Pinson, Sylvain Poisson, Le Quan Sang Kim-Han, Joelle Roume, Elodie Sanchez, Marjolaine Willems, Marianne Till, Catherine Vincent-Delorme, Christiane Mousson, Sandrine Vinault, Christine Binquet, Frédéric Huet, Pierre Sarda, Rémi Salomon, Stanislas Lyonnet, Damien Sanlaville, David Geneviève
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?